PLA2G4A anticorps (Ser505)
Aperçu rapide pour PLA2G4A anticorps (Ser505) (ABIN2138204)
Antigène
Voir toutes PLA2G4A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Ser505
-
Purification
- Purified
-
Immunogène
- CPLA2 antibody was raised in Rabbit using a synthesized non-phosphopeptide derived from human c-PLA2 around the phosphorylation site of Ser505 (P-L-SP-P-L) as the immunogen
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:1000, IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:20000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Purified IgG In PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C in small aliquots
-
-
- PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
-
Autre désignation
- CPLA2
-
Pathways
- Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Antigène
-